Fact CheckerSign in

NCT06309121Active, not recruiting

Effects of the Postbiotic Blend ABB C3 on Adiposity and Glucose Metabolism in Children and Adolescents

Source: ClinicalTrials.gov · Last updated 23 Mar 2026

Brief summary (registry, in English)

This study investigates the effects of a postbiotic combination called ABB C3 on reducing body fat and improving metabolic health in children and teenagers. The study consists of a 3-month trial with half participants taking ABB C3 and the other half a placebo, monitoring body composition and blood markers. Afterward, participants can continue with ABB C3 for an additional 3 months. The goal is to determine if ABB C3 is a safe and effective way to help young people improve their health by reducing body fat.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
70 (estimated)
First submitted
27 Feb 2024
Start date
10 Apr 2024
Primary completion date
31 Dec 2025
Lead sponsor
Fundació Sant Joan de Déu
Diseases
Obesity
NCT number
NCT06309121

What you commit to

  • Study type: Interventional
  • Planned participants: 70
  • From 10 Apr 2024 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Antibiotic or pre/pro/postbiotic consumption 2 - 4 weeks prior to starting the study
  • Individuals taking medications that may alter appetite or weight, with a recent change in prescription within the last 3 months or anticipated changes during the 2 months of participation

Other illness

  • History of bariatric surgery
  • Diabetes requiring insulin treatment

Lab values

  • Chronic diseases affecting glucose or lipid metabolism
  • Chronic medication affecting glucose or lipid metabolism, or inducing a pro-inflammatory state

Other

  • Severe intellectual disability
  • Pregnancy

Who the study is looking for

  • Age between 8- and 18-year-old
  • Obesity (BMI-SDS \> 2)

Age in the registry: 8 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Sant Joan de Déu
Coordinator of this site? Confirm its status
BarcelonaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.